Biotherapeutic firm launches valley fever study - DVM
News Center
DVM Featuring Information from:


Biotherapeutic firm launches valley fever study


Prescott, Ariz. -- Imulan Biotherapeutics announced a study to test the effectiveness of a new immuno-therapeutic to treat dogs with coccidiodomycosis, or valley fever.

Valley fever is an infection caused by the Coccidoides fungus and affects many species, including dogs and humans. The Southwest, specifically Arizona, is the primary area of infection in the United States.

The study will allow researchers to compare immunological vs. antifungal treatments in dogs to see how the treatments will work against human valley fever.

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.


Hospital Design
Hospital Design

A gutted building finds new life in Culver City, California



Experience World-Class Veterinary Education
Missed the show or want a refresh?
Buy Audio Files

Source: DVM360 MAGAZINE,
Click here